vs

Side-by-side financial comparison of Business First Bancshares, Inc. (BFST) and MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI). Click either name above to swap in a different company.

Business First Bancshares, Inc. is the larger business by last-quarter revenue ($83.1M vs $49.9M, roughly 1.7× MARAVAI LIFESCIENCES HOLDINGS, INC.). On growth, Business First Bancshares, Inc. posted the faster year-over-year revenue change (7.1% vs -11.8%). Business First Bancshares, Inc. produced more free cash flow last quarter ($92.0M vs $-24.9M). Over the past eight quarters, Business First Bancshares, Inc.'s revenue compounded faster (16.8% CAGR vs -11.9%).

First Citizens Bancshares, Inc. is a bank holding company based in Raleigh, North Carolina and one of the largest banks in the United States. Its primary subsidiary is First Citizens Bank, which operates over 500 branches in 23 states. A second subsidiary is Silicon Valley Bank, which operates 39 offices in 15 states.

Maravai LifeSciences Holdings is a global life sciences firm developing critical reagents, diagnostic products, and tech solutions to support biopharma research, drug development, clinical diagnostics, and cell/gene therapy manufacturing. It serves biotech, pharma, research bodies and labs worldwide across three core segments.

BFST vs MRVI — Head-to-Head

Bigger by revenue
BFST
BFST
1.7× larger
BFST
$83.1M
$49.9M
MRVI
Growing faster (revenue YoY)
BFST
BFST
+18.9% gap
BFST
7.1%
-11.8%
MRVI
More free cash flow
BFST
BFST
$116.9M more FCF
BFST
$92.0M
$-24.9M
MRVI
Faster 2-yr revenue CAGR
BFST
BFST
Annualised
BFST
16.8%
-11.9%
MRVI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BFST
BFST
MRVI
MRVI
Revenue
$83.1M
$49.9M
Net Profit
$-35.7M
Gross Margin
25.8%
Operating Margin
33.2%
-117.9%
Net Margin
-71.6%
Revenue YoY
7.1%
-11.8%
Net Profit YoY
-37.7%
EPS (diluted)
$0.71
$-0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BFST
BFST
MRVI
MRVI
Q4 25
$83.1M
$49.9M
Q3 25
$80.9M
$41.6M
Q2 25
$81.5M
$47.4M
Q1 25
$79.2M
$46.9M
Q4 24
$77.6M
$56.6M
Q3 24
$66.9M
$69.0M
Q2 24
$66.2M
$69.4M
Q1 24
$60.9M
$64.2M
Net Profit
BFST
BFST
MRVI
MRVI
Q4 25
$-35.7M
Q3 25
$22.9M
$-25.6M
Q2 25
$22.1M
$-39.6M
Q1 25
$20.5M
$-29.9M
Q4 24
$-25.9M
Q3 24
$17.8M
$-97.1M
Q2 24
$17.2M
$-9.8M
Q1 24
$13.6M
$-12.1M
Gross Margin
BFST
BFST
MRVI
MRVI
Q4 25
25.8%
Q3 25
13.6%
Q2 25
16.4%
Q1 25
16.5%
Q4 24
34.3%
Q3 24
46.7%
Q2 24
44.4%
Q1 24
40.3%
Operating Margin
BFST
BFST
MRVI
MRVI
Q4 25
33.2%
-117.9%
Q3 25
35.7%
-98.6%
Q2 25
34.4%
-139.8%
Q1 25
32.6%
-104.9%
Q4 24
27.5%
-66.7%
Q3 24
34.0%
-239.9%
Q2 24
32.9%
-19.4%
Q1 24
28.2%
-29.4%
Net Margin
BFST
BFST
MRVI
MRVI
Q4 25
-71.6%
Q3 25
28.2%
-61.4%
Q2 25
27.1%
-83.5%
Q1 25
25.9%
-63.9%
Q4 24
-45.8%
Q3 24
26.7%
-140.6%
Q2 24
26.0%
-14.1%
Q1 24
22.3%
-18.8%
EPS (diluted)
BFST
BFST
MRVI
MRVI
Q4 25
$0.71
$-0.24
Q3 25
$0.73
$-0.18
Q2 25
$0.70
$-0.27
Q1 25
$0.65
$-0.21
Q4 24
$0.51
$-0.21
Q3 24
$0.65
$-0.68
Q2 24
$0.62
$-0.07
Q1 24
$0.48
$-0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BFST
BFST
MRVI
MRVI
Cash + ST InvestmentsLiquidity on hand
$411.2M
$216.9M
Total DebtLower is stronger
$291.8M
Stockholders' EquityBook value
$896.9M
$212.4M
Total Assets
$8.2B
$770.6M
Debt / EquityLower = less leverage
1.37×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BFST
BFST
MRVI
MRVI
Q4 25
$411.2M
$216.9M
Q3 25
$399.1M
$243.6M
Q2 25
$495.8M
$269.9M
Q1 25
$312.9M
$285.1M
Q4 24
$319.1M
$322.4M
Q3 24
$213.2M
$578.2M
Q2 24
$208.1M
$573.2M
Q1 24
$185.9M
$561.7M
Total Debt
BFST
BFST
MRVI
MRVI
Q4 25
$291.8M
Q3 25
$292.8M
Q2 25
$293.9M
Q1 25
$294.9M
Q4 24
$295.9M
Q3 24
$521.7M
Q2 24
$522.5M
Q1 24
$523.3M
Stockholders' Equity
BFST
BFST
MRVI
MRVI
Q4 25
$896.9M
$212.4M
Q3 25
$878.4M
$245.4M
Q2 25
$848.4M
$265.9M
Q1 25
$826.3M
$300.6M
Q4 24
$799.5M
$325.3M
Q3 24
$699.5M
$344.9M
Q2 24
$664.5M
$434.7M
Q1 24
$649.0M
$410.7M
Total Assets
BFST
BFST
MRVI
MRVI
Q4 25
$8.2B
$770.6M
Q3 25
$8.0B
$849.2M
Q2 25
$7.9B
$897.0M
Q1 25
$7.8B
$959.8M
Q4 24
$7.9B
$1.0B
Q3 24
$6.9B
$1.3B
Q2 24
$6.7B
$1.4B
Q1 24
$6.7B
$1.4B
Debt / Equity
BFST
BFST
MRVI
MRVI
Q4 25
1.37×
Q3 25
1.19×
Q2 25
1.11×
Q1 25
0.98×
Q4 24
0.91×
Q3 24
1.51×
Q2 24
1.20×
Q1 24
1.27×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BFST
BFST
MRVI
MRVI
Operating Cash FlowLast quarter
$92.1M
$-22.8M
Free Cash FlowOCF − Capex
$92.0M
$-24.9M
FCF MarginFCF / Revenue
110.7%
-49.9%
Capex IntensityCapex / Revenue
0.1%
4.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$165.6M
$-70.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BFST
BFST
MRVI
MRVI
Q4 25
$92.1M
$-22.8M
Q3 25
$32.4M
$-15.2M
Q2 25
$14.0M
$-10.3M
Q1 25
$28.7M
$-9.4M
Q4 24
$61.4M
$-14.6M
Q3 24
$21.4M
$13.1M
Q2 24
$15.1M
$17.4M
Q1 24
$7.6M
$-8.5M
Free Cash Flow
BFST
BFST
MRVI
MRVI
Q4 25
$92.0M
$-24.9M
Q3 25
$32.1M
$-18.1M
Q2 25
$13.8M
$-13.1M
Q1 25
$27.7M
$-14.6M
Q4 24
$59.8M
$-20.5M
Q3 24
$21.0M
$4.5M
Q2 24
$14.0M
$7.9M
Q1 24
$7.2M
$-14.1M
FCF Margin
BFST
BFST
MRVI
MRVI
Q4 25
110.7%
-49.9%
Q3 25
39.6%
-43.4%
Q2 25
16.9%
-27.7%
Q1 25
34.9%
-31.2%
Q4 24
77.1%
-36.2%
Q3 24
31.4%
6.6%
Q2 24
21.2%
11.4%
Q1 24
11.8%
-22.0%
Capex Intensity
BFST
BFST
MRVI
MRVI
Q4 25
0.1%
4.2%
Q3 25
0.4%
7.0%
Q2 25
0.3%
6.1%
Q1 25
1.3%
11.2%
Q4 24
2.0%
10.3%
Q3 24
0.6%
12.4%
Q2 24
1.6%
13.8%
Q1 24
0.6%
8.8%
Cash Conversion
BFST
BFST
MRVI
MRVI
Q4 25
Q3 25
1.42×
Q2 25
0.63×
Q1 25
1.40×
Q4 24
Q3 24
1.20×
Q2 24
0.88×
Q1 24
0.56×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BFST
BFST

Segment breakdown not available.

MRVI
MRVI

Cygnus Segment$27.2M54%
Other$18.4M37%
Shipping And Handling$4.3M9%

Related Comparisons